QUIDEL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-02: Reporting owner TAMERIUS JOHN; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-11-16: Reporting owner SLACIK CHARLES P; Form 4; Security Non-Qualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-10-12: Reporting owner Russell Edward Keith; Form 4; Security Non-Qualified Stock Options; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-08-20: Reporting owner TAMERIUS JOHN; Form 4; Security Incentive Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-02 | TAMERIUS JOHN Officer (SVP, Strat & Ext Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,109 20,292 owned after | $8.50 exercise price | 2015-12-03 | |
| 2015-11-16 | SLACIK CHARLES P Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,009 4,009 owned after | $20.82 exercise price | 2015-11-18 | |
| 2015-10-12 | Russell Edward Keith Officer (SVP-Global Commercial Ops) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,211 35,211 owned after | $18.32 exercise price | 2015-10-14 | |
| 2015-08-20 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Incentive Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,000 0 owned after | $12.23 exercise price | 2015-08-24 | |
| 2015-08-17 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,811 1,811 owned after | $21.29 exercise price | 2015-08-19 | |
| 2015-07-31 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100 9,700 owned after | $12.63 exercise price | 2015-08-03 | |
| 2015-07-30 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,509 12,600 owned after | $12.63 exercise price | 2015-08-03 | |
| 2015-07-30 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,800 9,800 owned after | $12.63 exercise price | 2015-08-03 | |
| 2015-05-05 | WIDDER KENNETH J Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,021 7,021 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-05-05 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,021 7,021 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-05-05 | PULIDO MARK Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,215 9,215 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-05-05 | POLAN MARY LAKE PH D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,021 7,021 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-05-05 | Dammeyer Rodney F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,021 7,021 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-05-05 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,021 7,021 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-05-05 | Brown Thomas D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,021 7,021 owned after | $22.86 exercise price | 2015-05-06 | |
| 2015-02-05 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,846 32,846 owned after | $23.41 exercise price | 2015-02-09 | |
| 2015-02-05 | STEWARD RANDALL J Officer (Chief Financial Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,103 39,103 owned after | $23.41 exercise price | 2015-02-09 | |
| 2015-02-05 | SMITS MARK W Officer (SVP-Commercial Operations) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,846 32,846 owned after | $23.41 exercise price | 2015-02-09 | |
| 2015-02-05 | Kroll Werner Officer (SVP, R&D) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,192 35,192 owned after | $23.41 exercise price | 2015-02-09 | |
| 2015-02-05 | Bujarski Robert Joseph Officer (SVP, Bus Dev & Gen Counsel) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,192 35,192 owned after | $23.41 exercise price | 2015-02-09 | |
| 2015-02-05 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +93,847 93,847 owned after | $23.41 exercise price | 2015-02-09 | |
| 2015-01-19 | Abney Michael Donald Jr. Officer (SVP - Distribution) | 4 | Non-Qualified Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,807 14,807 owned after | $24.68 exercise price | 2015-01-21 |